Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition

Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition

  • December 2021 •
  • 53 pages •
  • Report ID: 6196739 •
  • Format: PDF
Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition

Summary
This report is an updated version of the 2019 edition and characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.

Scope
- This 53-page report gives important, expert insight you won’t find in any other source. 31 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives who must have deep understanding of the small molecule API marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy
- Overview of contract small molecule API facilities and the proportion of containment and controlled substance specialist capabilities
- Detailed view of the geographic distribution of small molecule API facilities
- Establishing which CMOs are most involved in contract small molecule API industry by facility count
- Analysis of M&A activity related to small molecule API facilities
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.